Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

NCT01399840

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +24 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
  • University of Wisconsin Madison, Wisconsin, United States
  • University College London London, United Kingdom
View Trial Details
Completed

Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS

NCT02018926

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Georegetown University Washington D.C., District of Columbia, United States
  • Lakes Research Miami Lakes, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00516503

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
View all 165 locations
View Trial Details
Completed

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

NCT00061763

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +28 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Stanford Hospital Stanford, California, United States
  • Northwest Medical Specialists Arlington Heights, Illinois, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
View Trial Details
Completed

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

NCT01606579

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Emory University / Winship Cancer Institute Atlanta, Georgia, United States
  • University of Massachusetts Medical Center Worcester, Massachusetts, United States
  • New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

NCT00045942

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • New York Weill Cornell Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

NCT02842229

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +28 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Durán I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • C.H. Universitario A Coruña A Coruña, La Coruña, Spain
View all 15 locations
View Trial Details
Completed

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

NCT02125877

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations
  • Children's Hospital of Orange County Onc Dept Orange, California, United States
  • Lurie Children's Hospital of Chicago Onc Dept Chicago, Illinois, United States
  • Children's Hospital Boston Department of Hematology Boston, Massachusetts, United States
  • Weill Cornell Medical College-Cornell University Onc Dept New York, United States
View all 51 locations
View Trial Details

Related conditions